1. Home
  2. ME
  3. ME News

Latest 23andMe Holding Co. (ME) News on July 27, 2024

23andMe to Report Q1 FY2025 Financial Results
ME

GlobeNewswire

a day ago

23andMe to Report Q1 FY2025 Financial Results

Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
ME

GlobeNewswire

2 days ago

Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research

23andMe and Nightingale partner to pilot blood-based risk detection panel
ME

Medical Device Network

25 days ago

23andMe and Nightingale partner to pilot blood-based risk detection panel

ME

MT Newswires

a month ago

23andMe to Offer Free Blood Testing for Members in Pilot Program

23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel
ME

GlobeNewswire

a month ago

23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel

ME

MT Newswires

2 months ago

Update: 23andMe Under Scrutiny by UK, Canadian Privacy Regulators Over October Data Breach

ME

MT Newswires

2 months ago

23andMe Under Scrutiny by UK, Canadian Privacy Regulators Over October 2023 Data Breach

BigBear.ai Stock: Buy, Sell, or Hold?
ME

Motley Fool

2 months ago

BigBear.ai Stock: Buy, Sell, or Hold?

Indonesia's first Olympic gymnast encourages others to 'dream higher'
ME

AFP

2 months ago

Indonesia's first Olympic gymnast encourages others to 'dream higher'

Where Will CrowdStrike Stock Be in 1 Year?
ME

Motley Fool

2 months ago

Where Will CrowdStrike Stock Be in 1 Year?

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp
ME

GuruFocus.com

2 months ago

Warren Buffett's Strategic Acquisition in Occidental Petroleum Corp

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...
ME

GuruFocus.com

2 months ago

Insider Sale: EVP, CEO of Patient Direct, Perry Bernocchi, Sells Shares of Owens & Minor ...

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)
ME

Simply Wall St.

2 months ago

A Look At The Intrinsic Value Of Deufol SE (HMSE:DE1)

Chemring Group First Half 2024 Earnings: EPS: UK£0.045 (vs UK£0.067 in 1H 2023)
ME

Simply Wall St.

2 months ago

Chemring Group First Half 2024 Earnings: EPS: UK£0.045 (vs UK£0.067 in 1H 2023)

VanEck Semiconductor ETF Is Riskier Than You Think
ME

Motley Fool

2 months ago

VanEck Semiconductor ETF Is Riskier Than You Think

23andMe Launches New Genetic Report on Bipolar Disorder
ME

GlobeNewswire

2 months ago

23andMe Launches New Genetic Report on Bipolar Disorder

Why 23andMe Stock Tumbled 10% on Tuesday
ME

Motley Fool

2 months ago

Why 23andMe Stock Tumbled 10% on Tuesday

23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community
ME

GlobeNewswire

2 months ago

23andMe and the Colorectal Cancer Alliance Collaborate to Help Advance Colorectal Cancer Research in the Black Community

23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
ME

GlobeNewswire

2 months ago

23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting

Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
ME

GlobeNewswire

2 months ago

Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history

23andMe Holding Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
ME

Simply Wall St.

2 months ago

23andMe Holding Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

ME

Thomson Reuters StreetEvents

2 months ago

Q4 2024 23andMe Holding Co. Earnings Call

ME

MT Newswires

2 months ago

23andMe Q4 Loss Widens, Revenue Decreases

23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results
ME

GlobeNewswire

2 months ago

23andMe Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results

ME

MT Newswires

2 months ago

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

ME

MT Newswires

2 months ago

Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading

ME

MT Newswires

2 months ago

23andMe Unit Offers Petros Pharmaceuticals' Impotency Medication

Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
ME

GlobeNewswire

2 months ago

Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals

Struggling 23andMe Granted Extension to Revive Stock Price
ME

Bloomberg

3 months ago

Struggling 23andMe Granted Extension to Revive Stock Price

23andMe to Report Q4 and Full Year FY2024 Financial Results
ME

GlobeNewswire

3 months ago

23andMe to Report Q4 and Full Year FY2024 Financial Results

7 Best Sites Like Ancestry.com to Research Your Family History
ME

Insider Monkey

3 months ago

7 Best Sites Like Ancestry.com to Research Your Family History

23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
ME

GlobeNewswire

3 months ago

23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
ME

Motley Fool

3 months ago

This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next

23andMe CEO Anne Wojcicki Says She’s Weighing Buyout Bid
ME

Barrons.com

3 months ago

23andMe CEO Anne Wojcicki Says She’s Weighing Buyout Bid

Stocks to Watch Thursday: TSMC, Netflix, Nvidia, Tesla
ME

The Wall Street Journal

3 months ago

Stocks to Watch Thursday: TSMC, Netflix, Nvidia, Tesla

23andMe Stock Jumps on News of Plans to Take It Private
ME

The Wall Street Journal

3 months ago

23andMe Stock Jumps on News of Plans to Take It Private

23andMe Jumps as CEO Floats Plan to Take DNA Tester Private
ME

Bloomberg

3 months ago

23andMe Jumps as CEO Floats Plan to Take DNA Tester Private

23andMe announces CEO’s intention to pursue a potential take-private
ME

GlobeNewswire

3 months ago

23andMe announces CEO’s intention to pursue a potential take-private

23andMe CEO plans to take company private
ME

MedTech Dive

3 months ago

23andMe CEO plans to take company private

ME

Reuters

3 months ago

23andMe CEO Wojcicki considering taking firm private, filing shows

23andMe CEO Anne Wojcicki Plans to Take Company Private
ME

The Wall Street Journal

3 months ago

23andMe CEO Anne Wojcicki Plans to Take Company Private

Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth?
ME

Simply Wall St.

3 months ago

Can 23andMe Holding (NASDAQ:ME) Afford To Invest In Growth?

23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
ME

GlobeNewswire

4 months ago

23andMe to Present Data on Two Clinical Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024

Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?
ME

Motley Fool

4 months ago

Billionaires Are Snapping Up Beaten-Down 23andMe Stock. Should You Follow Their Lead?

23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
ME

GlobeNewswire

4 months ago

23andMe Initiates Phase 1 Clinical Trial for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6

23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago
ME

GlobeNewswire

4 months ago

23andMe Launches New Feature Connecting Customers to Historical Individuals from Hundreds and Even Thousands of Years Ago

23andMe Launches New Genetic Reports on Common Forms of Cancer
ME

GlobeNewswire

5 months ago

23andMe Launches New Genetic Reports on Common Forms of Cancer

23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024
ME

GlobeNewswire

5 months ago

23andMe Announces Three Presentations from Clinical-Stage Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting 2024

20 Most Valuable Digital Health Companies In The US
ME

Insider Monkey

5 months ago

20 Most Valuable Digital Health Companies In The US

Is 23andMe Stock a Smart Buy Right Now?
ME

Motley Fool

5 months ago

Is 23andMe Stock a Smart Buy Right Now?

23andMe Holding Third Quarter 2024 Earnings: US$0.58 loss per share (vs US$0.20 loss in 3Q 2023)
ME

Simply Wall St.

6 months ago

23andMe Holding Third Quarter 2024 Earnings: US$0.58 loss per share (vs US$0.20 loss in 3Q 2023)

23andMe Stock Slides After DNA-Testing Company's Disappointing Results
ME

The Wall Street Journal

6 months ago

23andMe Stock Slides After DNA-Testing Company's Disappointing Results

23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Call Transcript
ME

Insider Monkey

6 months ago

23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Call Transcript

ME

Thomson Reuters StreetEvents

6 months ago

Q3 2024 23andMe Holding Co. Earnings Call

How 23AndMe Went From a $6 Billion Valuation to a Penny Stock
ME

WSJ

6 months ago

How 23AndMe Went From a $6 Billion Valuation to a Penny Stock

23andMe Mulls Possible Split, Shares Fall After Disappointing Results
ME

The Wall Street Journal

6 months ago

23andMe Mulls Possible Split, Shares Fall After Disappointing Results

Struggling 23andMe Is Exploring Splitting the DNA Company in Two
ME

Bloomberg

6 months ago

Struggling 23andMe Is Exploring Splitting the DNA Company in Two

23andMe Holding Co (ME) Faces Revenue Decline and Net Loss in Q3 FY24
ME

GuruFocus.com

6 months ago

23andMe Holding Co (ME) Faces Revenue Decline and Net Loss in Q3 FY24

23andMe Reports Third Quarter Fiscal 2024 Financial Results
ME

GlobeNewswire

6 months ago

23andMe Reports Third Quarter Fiscal 2024 Financial Results

SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
ME

Benzinga

6 months ago

SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy

Main Street is still investing like it’s 2023
ME

CNN Business

6 months ago

Main Street is still investing like it’s 2023

23andMe is low on cash and its stock is worth pennies. The CEO wants another chance
ME

CNN Business

6 months ago

23andMe is low on cash and its stock is worth pennies. The CEO wants another chance

ME

Business Wire

6 months ago

Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference

23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6
ME

GlobeNewswire

6 months ago

23andMe Announces FDA Clearance of IND Application for its Dual Mechanism Antibody, 23ME-01473, Targeting ULBP6

23andMe’s Fall From $6 Billion to Nearly $0
ME

The Wall Street Journal

6 months ago

23andMe’s Fall From $6 Billion to Nearly $0

23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
ME

GlobeNewswire

6 months ago

23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay

Shareholders in Revance Therapeutics (NASDAQ:RVNC) are in the red if they invested a year ago
ME

Simply Wall St.

6 months ago

Shareholders in Revance Therapeutics (NASDAQ:RVNC) are in the red if they invested a year ago

Burke & Herbert Financial Services Full Year 2023 Earnings: EPS: US$3.06 (vs US$5.93 in FY 2022)
ME

Simply Wall St.

6 months ago

Burke & Herbert Financial Services Full Year 2023 Earnings: EPS: US$3.06 (vs US$5.93 in FY 2022)

Summit Financial Group, Inc.'s (NASDAQ:SMMF) largest shareholders are individual investors with 53% ownership, institutions own 34%
ME

Simply Wall St.

6 months ago

Summit Financial Group, Inc.'s (NASDAQ:SMMF) largest shareholders are individual investors with 53% ownership, institutions own 34%

REGISTER | WEBINAR INVITATION: Capital Link’s 2024 Virtual Corporate Presentation Series
ME

GlobeNewswire

6 months ago

REGISTER | WEBINAR INVITATION: Capital Link’s 2024 Virtual Corporate Presentation Series

Burke & Herbert Financial Services Corp. Announces Fourth Quarter and Full Year 2023 Results and Declares Common Stock Dividend
ME

PR Newswire

6 months ago

Burke & Herbert Financial Services Corp. Announces Fourth Quarter and Full Year 2023 Results and Declares Common Stock Dividend

Haynes International (HAYN) Earnings Expected to Grow: What to Know Ahead of Q1 Release
ME

Zacks

6 months ago

Haynes International (HAYN) Earnings Expected to Grow: What to Know Ahead of Q1 Release

One Reservoir Media Insider Raised Stake By 37% In Previous Year
ME

Simply Wall St.

6 months ago

One Reservoir Media Insider Raised Stake By 37% In Previous Year

23andMe to Report FY2024 Third Quarter Financial Results
ME

GlobeNewswire

6 months ago

23andMe to Report FY2024 Third Quarter Financial Results

Chuck Royce Increases Stake in Haynes International Inc
ME

GuruFocus.com

6 months ago

Chuck Royce Increases Stake in Haynes International Inc

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide
ME

Food Dive

6 months ago

Oatly and Carvel partner to bring dairy-free flavors to stores nationwide

Vertical Software Stocks Q3 Earnings: Doximity (NYSE:DOCS) Best of the Bunch
ME

StockStory

6 months ago

Vertical Software Stocks Q3 Earnings: Doximity (NYSE:DOCS) Best of the Bunch

The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them
ME

Motley Fool

6 months ago

The 3 Worst Stock Investments I Ever Made -- and What I Learned From Them

Oil-Dri Corporation of America's (NYSE:ODC) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
ME

Simply Wall St.

6 months ago

Oil-Dri Corporation of America's (NYSE:ODC) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Doherty Enterprises Inc. Expands Restaurant Portfolio in New York with Acquisition of 21 Applebee's® Restaurants formerly owned by Apple Metro
ME

PR Newswire

6 months ago

Doherty Enterprises Inc. Expands Restaurant Portfolio in New York with Acquisition of 21 Applebee's® Restaurants formerly owned by Apple Metro

Basic Materials Roundup: Market Talk
ME

The Wall Street Journal

6 months ago

Basic Materials Roundup: Market Talk

Declining Stock and Solid Fundamentals: Is The Market Wrong About Medifast, Inc. (NYSE:MED)?
ME

Simply Wall St.

6 months ago

Declining Stock and Solid Fundamentals: Is The Market Wrong About Medifast, Inc. (NYSE:MED)?

MoneyLion Inc. (ML) Is a Great Choice for 'Trend' Investors, Here's Why
ME

Zacks

6 months ago

MoneyLion Inc. (ML) Is a Great Choice for 'Trend' Investors, Here's Why

Monro, Inc. to Report Third Quarter Fiscal 2024 Earnings on January 24, 2024
ME

Business Wire

7 months ago

Monro, Inc. to Report Third Quarter Fiscal 2024 Earnings on January 24, 2024

Denny's (DENN) Reports Q4 & Fiscal 2023 Preliminary Results
ME

Zacks

7 months ago

Denny's (DENN) Reports Q4 & Fiscal 2023 Preliminary Results

Here's Why You Should Add Olympic Steel (ZEUS) to Your Portfolio
ME

Zacks

7 months ago

Here's Why You Should Add Olympic Steel (ZEUS) to Your Portfolio

ME

Reuters

7 months ago

UPDATE 2-Allogene to cut 22% of its workforce

ME

Reuters

7 months ago

Allogene to cut 22% of its workforce

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma
ME

GlobeNewswire

7 months ago

Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro Diagnostic for Use in ALPHA3, the First Pivotal Trial for Frontline Consolidation in Large B-Cell Lymphoma

Ur-Energy Inc. (TSE:URE) most popular amongst individual investors who own 49% of the shares, institutions hold 40%
ME

Simply Wall St.

7 months ago

Ur-Energy Inc. (TSE:URE) most popular amongst individual investors who own 49% of the shares, institutions hold 40%

Mesa Labs Completes the Acquisition of GKE Science & Technology Co.
ME

GlobeNewswire

7 months ago

Mesa Labs Completes the Acquisition of GKE Science & Technology Co.

Chuy's Holdings (CHUY) Just Overtook the 200-Day Moving Average
ME

Zacks

7 months ago

Chuy's Holdings (CHUY) Just Overtook the 200-Day Moving Average

What Makes Bank of Hawaii Corporation (BOH) a Good Short Position?
ME

Insider Monkey

7 months ago

What Makes Bank of Hawaii Corporation (BOH) a Good Short Position?

Why CommScope Stock Was on Fire Today
ME

Motley Fool

7 months ago

Why CommScope Stock Was on Fire Today

ME

Business Wire

7 months ago

Certain Eaton Vance Municipal Closed-End Funds Announce Distribution Updates

CommScope Named to Newsweek’s America’s Most Responsible Companies 2024 and Newsweek’s America’s Greatest Workplaces for Diversity 2024 Lists
ME

Business Wire

7 months ago

CommScope Named to Newsweek’s America’s Most Responsible Companies 2024 and Newsweek’s America’s Greatest Workplaces for Diversity 2024 Lists

Ezcorp (EZPW) Flat As Market Sinks: What You Should Know
ME

Zacks

7 months ago

Ezcorp (EZPW) Flat As Market Sinks: What You Should Know

Retail investors account for 35% of 23andMe Holding Co.'s (NASDAQ:ME) ownership, while institutions account for 35%
ME

Simply Wall St.

7 months ago

Retail investors account for 35% of 23andMe Holding Co.'s (NASDAQ:ME) ownership, while institutions account for 35%

With 55% institutional ownership, Ellington Financial Inc. (NYSE:EFC) is a favorite amongst the big guns
ME

Simply Wall St.

7 months ago

With 55% institutional ownership, Ellington Financial Inc. (NYSE:EFC) is a favorite amongst the big guns

Chuy's Holdings, Inc.'s (NASDAQ:CHUY) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
ME

Simply Wall St.

7 months ago

Chuy's Holdings, Inc.'s (NASDAQ:CHUY) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

Share on Social Networks: